ArticleBMC medicine2023

Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies.

Xingsheng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.